MYERS SCOTT DUNSETH purchased 8.1% of their position (21K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $29.4K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/30/2025ACC: 0001725160-25-000094
Director
Since Nov 2024
+21K
Net shares
Net buyer
$29.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
21K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21K
Price / share
$1.40
Trade value
$29.37K
% of position
8.1%
4/30/2025
260.19K→281.19K
Total
Net shares
+21K
Net value
$29.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2025 | P · Purchase | +21K | $1.40 | $29.37K | 8.1% | 260.19K | 281.19K |
| Total | +21K | $29.37K | ||||||
Derivative Transactions0
No derivative transactions reported